Nykode Therapeutics AS (VACBF) Short Interest Ratio & Short Volume $0.52 0.00 (0.00%) (As of 11/1/2024 ET) Add Compare Share Share Short Interest Stock AnalysisChartShort Interest Nykode Therapeutics AS Short Interest DataNykode Therapeutics AS (VACBF) has a short interest of 2.21 million shares. This marks a -1.85% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.0, indicating that it would take 0.0 days of the average trading volume of 500 shares to cover all short positions.Current Short Interest2,210,700 sharesPrevious Short Interest2,252,400 sharesChange Vs. Previous Month-1.85%Dollar Volume Sold Short$1.15 millionShort Interest Ratio0.0 Days to CoverLast Record DateOctober 15, 2024Today's Trading Volume0 sharesAverage Trading Volume500 sharesToday's Volume Vs. Average0% Short Selling Nykode Therapeutics AS? Sign up to receive the latest short interest report for Nykode Therapeutics AS and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartVACBF Short Interest Over TimeVACBF Days to Cover Over TimeVACBF Percentage of Float Shorted Over Time Ad Timothy SykesThe most productive 1 min of your day… This next step in your trading career is a simple, yet important one. I want you to take 1 minute to sign up for FREE algo alerts powered by StocksToTrade.>> Click Here To Sign Up For StocksToTrade’s Algo Alerts << Nykode Therapeutics AS Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/15/20242,210,700 shares $1.15 million -1.9%N/A0 $0.52 9/30/20242,252,400 shares $1.17 million -2.2%N/A0 $0.52 9/15/20242,303,400 shares $1.20 million -2.9%N/A23034 $0.52 8/31/20242,371,000 shares $1.25 million +2.2%N/A3951.7 $0.53 8/15/20242,319,400 shares $3.48 million +1.1%N/A0 $1.50 7/31/20242,294,900 shares $3.44 million +10.4%N/A0 $1.50 Get the Latest News and Ratings for VACBF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Nykode Therapeutics AS and its competitors with MarketBeat's FREE daily newsletter. 7/15/20242,078,700 shares $3.12 million +5.1%N/A0 $1.50 6/30/20241,977,700 shares $2.97 million -1.2%N/A0 $1.50 6/15/20242,002,400 shares $3.00 million No ChangeN/A0 $1.50 5/31/20242,002,400 shares $3.00 million +7.9%N/A0 $1.50 5/15/20241,855,700 shares $2.78 million -0.6%N/A976.7 $1.50 4/30/20241,866,300 shares $2.33 million +6.7%N/A0 $1.25 4/15/20241,748,600 shares $2.19 million +7.7%N/A17486 $1.25 3/31/20241,623,000 shares $2.56 million -14.0%N/A16230 $1.58 3/15/20241,887,300 shares $2.98 million +77.3%N/A419.4 $1.58 2/29/20241,064,500 shares $1.68 million -9.1%N/A0 $1.58 2/15/20241,171,600 shares $1.85 million +26.3%N/A0 $1.58 1/15/2024768,100 shares $1.21 million +15.5%N/A0 $1.58 12/31/2023664,800 shares $1.05 million +12.1%N/A0 $1.58 12/15/2023593,100 shares $937,098.00 No ChangeN/A0 $1.58 11/30/2023593,100 shares $937,098.00 -30.2%N/A0 $1.58 11/15/2023849,200 shares $1.34 million -67.0%N/A0 $1.58 10/31/20232,576,500 shares $4.07 million -0.1%N/A25765 $1.58 10/15/20232,578,600 shares $5.80 million +5.3%N/A25786 $2.25 9/30/20232,448,000 shares $5.78 million +0.9%N/A0 $2.36 9/15/20232,426,800 shares $5.73 million +1.9%N/A0 $2.36 8/31/20232,382,800 shares $5.62 million No ChangeN/A0 $2.36 VACBF Short Interest - Frequently Asked Questions What is Nykode Therapeutics AS's current short interest? Short interest is the volume of Nykode Therapeutics AS shares that have been sold short but have not yet been covered or closed out. As of October 15th, traders have sold 2,210,700 shares of VACBF short. Learn More on Nykode Therapeutics AS's current short interest. Is Nykode Therapeutics AS's short interest increasing or decreasing? Nykode Therapeutics AS saw a decrease in short interest in the month of October. As of October 15th, there was short interest totaling 2,210,700 shares, a decrease of 1.9% from the previous total of 2,252,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.14 billion), AppLovin Co. ($3.15 billion), Paychex, Inc. ($2.69 billion), Nu Holdings Ltd. ($2.48 billion), Cencora, Inc. ($2.24 billion), International Paper ($2.04 billion), Tractor Supply ($1.96 billion), Coinbase Global, Inc. ($1.93 billion), Moderna, Inc. ($1.91 billion), and SoFi Technologies, Inc. ($1.84 billion). View all of the most shorted stocks. What does it mean to sell short Nykode Therapeutics AS stock? Short selling VACBF is an investing strategy that aims to generate trading profit from Nykode Therapeutics AS as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Nykode Therapeutics AS? A short squeeze for Nykode Therapeutics AS occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of VACBF, which in turn drives the price of the stock up even further. How often is Nykode Therapeutics AS's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including VACBF, twice per month. The most recent reporting period available is October, 15 2024. More Short Interest Resources from MarketBeat Related Companies 180 Life Sciences Short Squeeze 3SBio Short Squeeze Algernon Pharmaceuticals Short Squeeze Alpha Tau Medical Short Squeeze Anew Medical Short Squeeze Apollomics Short Squeeze Ascentage Pharma Group International Short Squeeze Ascletis Pharma Short Squeeze Avacta Group Short Squeeze Awakn Life Sciences Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:VACBF) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredMusk Says ‘Dollar Will Be Worth Nothing…’Elon Musk just issued an urgent warning… It's no secret that Musk is able to move markets with his words…Crypto 101 Media | Sponsored[Just Released] Jovine's Emergency Briefing insidePeople didn't believe Jovine when he predicted the 2008 financial crisis over a year in advance. But some read...Behind the Markets | SponsoredHe made 1,303,329 in 12 months after Biden won…Tim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… ...Timothy Sykes | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nykode Therapeutics AS Please log in to your account or sign up in order to add this asset to your watchlist. Share Nykode Therapeutics AS With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
